Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab.

Giraldo NA, Nguyen P, Engle EL, Kaunitz GJ, Cottrell TR, Berry S, Green B, Soni A, Cuda JD, Stein JE, Sunshine JC, Succaria F, Xu H, Ogurtsova A, Danilova L, Church CD, Miller NJ, Fling S, Lundgren L, Ramchurren N, Yearley JH, Lipson EJ, Cheever M, Anders RA, Nghiem PT, Topalian SL, Taube JM.

J Immunother Cancer. 2018 Oct 1;6(1):99. doi: 10.1186/s40425-018-0404-0.

2.

Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique.

Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, Hanson R.

Curr Stem Cell Res Ther. 2011 Dec;6(4):368-78.

PMID:
22023622
3.

Parks are the answer: help us prove it.

Cheever M.

J Phys Act Health. 2011 Jan;8 Suppl 1:S143-4.

PMID:
21350256
4.

Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique.

Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W.

Curr Stem Cell Res Ther. 2010 Mar;5(1):81-93.

PMID:
19951252
5.

Requirements for T cell recognition and elimination of retrovirally-transformed cells.

Greenberg P, Klarnet J, Kern D, Okuno K, Riddell S, Cheever M.

Princess Takamatsu Symp. 1988;19:287-301.

PMID:
2479634
6.

Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease.

Witherspoon RP, Matthews D, Storb R, Atkinson K, Cheever M, Deeg HJ, Doney K, Kalbfleisch J, Noel D, Prentice R, et al.

Transplantation. 1984 Feb;37(2):145-50.

PMID:
6420960

Supplemental Content

Loading ...
Support Center